Abbott Laboratories vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
7.1
Buy
Overall
6.2
Hold
Quality
Health
Growth
Valuation
Sentiment
ABT
Analysts see 31% upside to $118.64 consensus target.
⚠ earnings contracting 20% year-over-year.
UNH
82% of 28 covering analysts rate it Buy or Strong Buy.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $118.64 (+30.8%)
25 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
ABT
UNH
25.4×
Trailing P/E
27.9×
15.0×
Forward P/E
17.8×
13.9%
Profit Margin
2.7%
56.5%
Gross Margin
18.8%
—
ROE
12.2%
7.8%
Revenue Growth
2.0%
-19.7%
Earnings Growth
0.7%
0.78
Beta
0.41
—
Price / Book
—
$157.6B
Market Cap
$335.0B
$90 – $139
52-Week Range
$235 – $412
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.